Skip to content
Screener

Alumis Inc. ALMS Total Current Liabilities

Total Current Liabilities at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$18.66B-32.2%
Amgen logo
AmgenAMGN
$25.5B+24.5%
Immunome logo
ImmunomeIMNM
$27.41M-11.0%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$16.63M+41.9%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$21.13M+128%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$283.66M+19.8%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Operating income-$98.4M+3.1%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.54B+686%
Enterprise value$3.52B+940%
P/S421.8×

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Alumis Inc.’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:16 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001847367-26-000010
(in thousands, except share and per share amounts)March 31, 2026December 31, 2025
Other accrued expenses and current liabilities12,58822,303
Deferred revenue, current6,3281,458
Operating lease liabilities, current4,4424,670
Total current liabilities70,90473,318
Operating lease liabilities, non-current31,22232,244
Deferred tax liability2,1402,140
Share repurchase liability94123
Deferred revenue, non-current2,611

Item 1. Financial Statements (Unaudited)

FAQ

What is Alumis Inc.'s total current liabilities?
Alumis Inc. (ALMS) reported total current liabilities of $70.9M in Q1 2026.
How has Alumis Inc.'s total current liabilities changed year-over-year?
Alumis Inc.'s total current liabilities increased by 17.3% year-over-year, from $60.45M to $70.9M.
What is the long-term trend for Alumis Inc.'s total current liabilities?
Over 2 years (2023 to 2025), Alumis Inc.'s total current liabilities has grown at a 87.4% compound annual growth rate (CAGR), from $20.87M to $73.32M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Alumis Inc.'s total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude